These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 112917)

  • 21. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
    Quémard A; Lacave C; Lanéelle G
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1035-9. PubMed ID: 1656850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanism of isoniazid killing: clarity through the scope of genetics.
    Vilchèze C; Jacobs WR
    Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
    Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
    Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.
    Mdluli K; Slayden RA; Zhu Y; Ramaswamy S; Pan X; Mead D; Crane DD; Musser JM; Barry CE
    Science; 1998 Jun; 280(5369):1607-10. PubMed ID: 9616124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid.
    Jyoti MA; Zerin T; Kim TH; Hwang TS; Jang WS; Nam KW; Song HY
    Pulm Pharmacol Ther; 2015 Aug; 33():17-24. PubMed ID: 26021818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling a tuberculosis drug target.
    Travis J
    Science; 1994 Jan; 263(5144):172. PubMed ID: 8284668
    [No Abstract]   [Full Text] [Related]  

  • 28. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
    Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
    Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of the monounsaturated long chain fatty acids of Mycobacterium tuberculosis.
    Takayama K; Qureshi N
    Lipids; 1978 Sep; 13(9):575-9. PubMed ID: 101728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
    Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M
    J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis.
    Garbe TR; Hibler NS; Deretic V
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1754-6. PubMed ID: 8807080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug susceptibility testing of mature Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis biofilms with calorimetry and laser spectroscopy.
    Solokhina A; Bonkat G; Kulchavenya E; Braissant O
    Tuberculosis (Edinb); 2018 Dec; 113():91-98. PubMed ID: 30514518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The mycolic acids analysis with HPLC technique in drug susceptibility testing of Mycobacterium tuberculosis strains].
    Walkiewicz R; Grubek-Jaworska H; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):89-94. PubMed ID: 17175985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra.
    Shoeb HA; Bowman BU; Ottolenghi AC; Merola AJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):404-7. PubMed ID: 2986545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid.
    Takayama K; Wang L; Merkal RS
    Antimicrob Agents Chemother; 1973 Jul; 4(1):62-5. PubMed ID: 4208900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.
    Slayden RA; Lee RE; Armour JW; Cooper AM; Orme IM; Brennan PJ; Besra GS
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2813-9. PubMed ID: 9124847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis.
    Garza-González E; Guerrero-Olazarán M; Tijerina-Menchaca R; Viader-Salvadó JM
    J Clin Microbiol; 1997 May; 35(5):1287-9. PubMed ID: 9114429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of fatty acids by extracts of mycobacteria and the absence of inhibition by isoniazid.
    Winder FG; Brennan P; Ratledge C
    Biochem J; 1964 Dec; 93(3):635-40. PubMed ID: 4953848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.